Shares of Novo Nordisk and Eli Lilly & Co. dropped early Tuesday after President Joe Biden and Sen. Bernie Sanders took aim at obesity and diabetes drug prices in a USA Today opinion piece.
Lennar’s stock got chopped down Tuesday after a Raymond James analyst backed away from his longtime bullish call on the home builder — citing margin concerns and other company-specific “overhangs.”